| 651 |
UTROGESTAN 100 MG |
MICRONIZED PROGESTERONE 100 MG |
SOFT CAPSULE |
ALU-BLISTER |
DISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY AND OF ABORTION. |
NULL |
EXAMED CO.,LTD |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
04 I 4429/18 |
03-MAR-2025 |
02-MAR-2030 |
View |
| 652 |
UTROGESTAN 200 MG |
PROGESTERONE MICRONIZED PH EUR 200 MG |
SOFT CAPSULE, VAGINAL ROUTE |
ALU-PVC BLISTER PACK |
SUPPORT DURING OVARIAN INSUFFICIENCY OR COMPLETE OVARIAN FAILURE IN WOMEN LACKING OVARIAN FUNCTION, LUTEAL PHASE SUPPORT DURING IN-VITRO FERTILIZATION CYCLE, MENACE OF ABORTION OR PREVENTION OF RECURRENT SPONTANEOUS ABORTIONS DUE TO LUTEAL PHASE DEFECT UP TO 12TH WEEK OF PREGNANCY, MENACE OF PRETERM DELIVERY |
NULL |
EXAMED CO.,LTD |
CYNDEA PHARMA, S.L. |
BELGIUM |
CERTIFICATE RELEASED |
01 I 5169/22 |
25-OCT-2024 |
24-OCT-2029 |
View |
| 653 |
UTROGESTAN 200 MG |
PROGESTERONE MICRONIZED PH EUR 200 MG |
SOFT CAPSULE, ORAL ROUTE |
ALU-PVC BLISTER PACK |
DISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY |
NULL |
EXAMED CO.,LTD |
CYNDEA PHARMA, S.L. |
BELGIUM |
CERTIFICATE RELEASED |
01 I 5170/22 |
25-OCT-2024 |
24-OCT-2029 |
View |
| 654 |
MUSLEXAC |
PARACETAMOL 500 MG, ORPHENADRINE CITRATE 35 MG |
TABLET |
BLISTERPACK AND BOTTLE |
ANALGESIC AND RELIEF PAIN DUE TO SPASM OF SKELETAL MUSCLE |
NULL |
DKSH LAOS COMPANY LIMITED |
INPAC PHARMA CO.,LTD |
THAILAND |
STEP 1: RECEIVE (RENEW) |
06 I 5238/22 |
02-JUN-2022 |
01-JUN-2025 |
View |
| 655 |
UTROGESTAN 200 MG |
MICRONIZED PROGESTERONE 200 MG |
SOFT CAPSULE |
ALU-BLISTER |
DISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY AND OF ABORTION.
|
NULL |
EXAMED CO.,LTD |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
04 I 4430/18 |
03-MAR-2025 |
02-MAR-2030 |
View |
| 656 |
UTROGESTAN VAGINAL 300 MG |
PROGESTERONE 300 MG |
CAPSULE |
BOTTLE |
IN ADULT WOMEN FOR SUPPLEMENTATION OF THE LUTEAL PHASE DURING ASSITED REPRODUCTIVE TECHNOLOGY CYCLES. |
NULL |
EXAMED CO.,LTD |
CYNDEA PHARMA, S.L. |
SWEDEN |
CERTIFICATE RELEASED |
04 I 5732/24 |
2024-04-26 |
2027-04-25 |
View |
| 657 |
VITAXON INJECTION 500 MCG |
MECOBALAMIN 500 MCG/ML |
SOLUTION FOR INJECTION |
AMPOULES |
TREATMENT OF PERIPHERAL NEUROPATHIES, SCIATICA PAIN AND LUMBAGO, TREATMENT OF MAGALOBLASTIC ANEMIAS AND ANEMIA OF TOPICAL SPRUE, IDIOPATHIC STEATORRHOEA, GLUTEN-INDUCED ENTEROPATHY, REGIONAL ILEITIS, ILEAL RESECTION, GRANULOMAS.. |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4385/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 658 |
VITAXON TABLET 500 MCG |
MECOBALAMIN 500 MCG |
FILM-COATED TABLETS |
ALU-ALU |
TREATMENT OF PERIPHERAL NEUROPATHIES, SCIATICA PAIN AND LUMBAGO, TREATMENT OF MAGALOBLASTIC ANEMIAS AND ANEMIA OF TOPICAL SPRUE, IDIOPATHIC STEATORRHOEA, GLUTEN-INDUCED ENTEROPATHY, REGIONAL ILEITIS, ILEAL RESECTION, GRANULOMAS.. |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4384/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 659 |
XANILO 30 MG DDR CAPSULE |
DEXLANSOPRAZOLE DUAL DELAYED RELEASE PELLETS EQ.TO DEXLANSOPRAZOLE 30 MG |
CAPSULE |
ALU-ALU BLISTER |
• Healing of Erosive Esophagitis
Xanilo is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks.
•Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
Xanilo is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age.
• Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Xanilois indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal
reflux disease (GERD) for four weeks. |
NULL |
EXAMED CO.,LTD |
MARTIN DOW LTD |
PAKISTAN |
CERTIFICATE RELEASED |
01 I 5857/25 |
23-JAN-2025 |
22-JAN-2030 |
View |
| 660 |
XANILO 60 MG DDR CAPSULE |
DEXLANSOPRAZOLE DUAL DELAYED RELEASE PELLETS EQ.TO DEXLANSOPRAZOLE 60 MG |
CAPSULE |
ALU-ALU BLISTER |
• Healing of Erosive Esophagitis
Xanilo is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks.
•Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
Xanilo is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in
patients 12 to 17 years of age.
• Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Xanilois indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal
reflux disease (GERD) for four weeks. |
NULL |
EXAMED CO.,LTD |
MARTIN DOW LTD |
PAKISTAN |
CERTIFICATE RELEASED |
01 I 5858/25 |
23-JAN-2025 |
22-JAN-2030 |
View |
